- Home
- ERAS vs GSL Comparison
ERAS vs GSL Comparison
Compare ERAS & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- GSL
- Stock Information
- Founded
- ERAS 2018
- GSL 2007
- Country
- ERAS United States
- GSL Greece
- Employees
- ERAS N/A
- GSL N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- GSL Marine Transportation
- Sector
- ERAS Health Care
- GSL Consumer Discretionary
- Exchange
- ERAS Nasdaq
- GSL Nasdaq
- Market Cap
- ERAS 723.8M
- GSL 781.1M
- IPO Year
- ERAS 2021
- GSL 2006
- Fundamental
- Price
- ERAS $1.90
- GSL $21.37
- Analyst Decision
- ERAS Strong Buy
- GSL Strong Buy
- Analyst Count
- ERAS 5
- GSL 1
- Target Price
- ERAS $5.70
- GSL $29.00
- AVG Volume (30 Days)
- ERAS 1.5M
- GSL 283.4K
- Earning Date
- ERAS 11-12-2024
- GSL 03-03-2025
- Dividend Yield
- ERAS N/A
- GSL 7.72%
- EPS Growth
- ERAS N/A
- GSL 7.30
- EPS
- ERAS N/A
- GSL 8.96
- Revenue
- ERAS N/A
- GSL $701,476,000.00
- Revenue This Year
- ERAS N/A
- GSL $6.45
- Revenue Next Year
- ERAS N/A
- GSL N/A
- P/E Ratio
- ERAS N/A
- GSL $2.39
- Revenue Growth
- ERAS N/A
- GSL 8.60
- 52 Week Low
- ERAS $1.64
- GSL $18.75
- 52 Week High
- ERAS $3.45
- GSL $30.32
- Technical
- Relative Strength Index (RSI)
- ERAS 29.70
- GSL 41.74
- Support Level
- ERAS $1.77
- GSL $21.78
- Resistance Level
- ERAS $2.84
- GSL $22.51
- Average True Range (ATR)
- ERAS 0.18
- GSL 0.51
- MACD
- ERAS -0.07
- GSL -0.04
- Stochastic Oscillator
- ERAS 12.15
- GSL 16.20
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.